• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Adicet Bio Inc (NQ: ACET )

    1.100 -0.050 (-4.35%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,185,752
    Open 1.160
    Bid (Size) 1.090 (14)
    Ask (Size) 1.130 (17)
    Prev. Close 1.150
    Today's Range 1.090 - 1.160
    52wk Range 1.100 - 3.770
    Shares Outstanding 42,957,586
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
    From Adicet Bio, Inc.
    Via Business Wire

    Performance

    YTD
    -45.27%
    -45.27%
    1 Month
    -23.61%
    -23.61%
    3 Month
    -54.17%
    -54.17%
    6 Month
    -45.27%
    -45.27%
    1 Year
    -59.71%
    -59.71%

    More News

    Read More
    Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
    Via InvestorPlace
    Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio: Q4 Earnings Insights
    Via Benzinga
    Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
    From Adicet Bio, Inc.
    Via Business Wire
    ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024
    Via InvestorPlace
    Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
    Via InvestorPlace
    ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023
    Via InvestorPlace
    Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
    From Adicet Bio, Inc.
    Via Business Wire
    3 High-Risk Stocks That Could Pay Off in the Millions
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    7 Top-Tier Penny Stocks for a Smart Bet
    Via InvestorPlace
    Topics Stocks
    Exposures US Equities
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Via InvestorPlace
    Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    From Adicet Bio, Inc.
    Via Business Wire
    Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.